Paychex, Inc. vs Revolution Medicines Inc. Common Stock — how do they compare? Paychex, Inc. trades at $104.43 (market cap $37.19B), while Revolution Medicines Inc. Common Stock trades at $191.29 (market cap $40.32B). The key difference: Paychex, Inc. and Revolution Medicines Inc. Common Stock are close in size by market cap, and Paychex, Inc. pays a 4.56% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Paychex, Inc. for 56 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| PAYX | RVMD | |
|---|---|---|
Market Cap | $37.19B | $40.32B |
Volume | 3,344,316 | 4,855,734 |
Sector | Industrials | Health |
52-Week High | $128.59 | $221.15 |
52-Week Low | $85.57 | $47.50 |
Typical Hold Time | 56 Days | 0 Days |
Enterprise Value | $40.87B | $37.02B |
Dividend Yield | 4.56% | — |
Signals from Pluang's Aura AI — not financial advice
Paychex (PAYX) trades at $104.62, up 3.02% today, with a mixed technical outlook showing bullish overall signals but bearish moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.34 beating the $1.32 estimate, and maintains robust profitability with a 27.35% net income margin. Recent news highlights a 14% stock decline despite earnings strength, raising questions about dividend sustainability amid investor focus on cash flow.
The outlook is cautiously optimistic, with a consensus price target of $111 suggesting modest upside. Key opportunities include steady revenue growth and high margins, but risks involve labor market sensitivity and elevated valuation multiples. The stock's recent volatility reflects divergent analyst views, with 67.74% holding a neutral rating.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →